Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445144 · ClinicalTrials.gov registry record
Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Terminated
- Registry status
- 26
- Enrollment target
NCT02445144: Clinical Trial study, sponsored by Albert Einstein College of Medicine.
NCT02445144 is a clinical trial that was terminated before completion, run by Albert Einstein College of Medicine. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445144 was terminated before completion, sponsored by Albert Einstein College of Medicine.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Patients with sickle cell anemia (SCA) are at an increased risk for damage to brain tissue due to their disease. The investigators are interested in how blood flow and cerebral inflammation are different in SCA patients and how that affects brain tissue- the investigators will use a relatively new set of dynamic MRI techniques to evaluate these parameters. The investigators will image participants with both SCA and matched controls with non-invasive MRI.
Primary Outcome
CBF will be measured by continuous arterial spin labeling (CASL) MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-11 |
| Est. Completion | 2020-05-04 |
Why NCT02445144 stopped before completion
NCT02445144 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02445144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02445144 about?
NCT02445144 is a clinical study titled "Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease". Patients with sickle cell anemia (SCA) are at an increased risk for damage to brain tissue due to their disease. The investigators are interested in how blood flow and cerebral inflammation are different in SCA patients and how that affects brain tissue- the investigators will use a relatively new s...
What is the current status of trial NCT02445144?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2014-11. Estimated completion is 2020-05-04.
Who is sponsoring clinical trial NCT02445144?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia